Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Share Its Reliability
Source: 247wallst.com
The article highlights Procter & Gamble, Johnson & Johnson, Coca-Cola, ADP and Lowe’s as dividend payers whose payouts are covered by cash flow and whose earnings payout ratios are about 41%–62%; P&G has raised its dividend for 70 consecutive years, while J&J reports 64 consecutive increases. Cash-flow coverage is strongest at ADP, at about 2.07 times dividends paid, while Lowe’s has the lowest payout ratio but higher leverage and weak home-improvement demand. Growth and risks vary: Coca-Cola expects 9%–10% comparable EPS growth, whereas P&G cites an approximately $1 billion after-tax cost headwind and Lowe’s comparable transactions fell 2.1%.
Analysis
The key portfolio implication is not dividend safety but the price paid for defensive cash flows. A long raise streak can cushion drawdowns, yet it does little to protect total return if rates reprice higher or earnings growth disappoints; a crowded “reliable income” trade can therefore sell off alongside higher-duration equities. The article’s coverage comparisons are also not fully apples-to-apples: ADP is assessed on operating cash flow, while other names are discussed using free cash flow, and working-capital/client-fund timing can make ADP’s cash conversion look different from distributable cash generation.
Among the group, PG looks the cleaner defensive relative-value candidate than KO if the priority is valuation discipline, but its input-cost pressure makes the near-term margin path the test—not its dividend record. KO’s stronger stated growth outlook may justify a premium, though the IRS dispute is a cash-flow tail risk rather than a routine quarterly catalyst. LOW’s lower multiple is not automatically a value signal: leverage and housing-sensitive demand make earnings more cyclical than its dividend streak suggests. ADP’s hiring exposure is a slow-moving risk; JNJ’s product transition and legal overhangs remain name-specific, not evidence that the broader payout cohort is impaired.
Near term, the likely effect is modest sentiment support, not a durable earnings catalyst. Over 1–3 months, watch guidance, input costs, hiring metrics and legal developments. Over 6–18 months, rates and consumer/housing demand will determine whether these stocks earn defensive multiples. The contrarian risk is treating “covered” dividends as bond substitutes: payout continuity can coexist with weak real total returns.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
Key Decisions for Investors
- Do not buy the five-stock basket solely for streaks or headline yields. For defensive exposure, consider PG over KO only on a relative-value basis; verify comparable forward valuation and whether input-cost guidance stabilizes before initiating. Reassess if PG cuts its organic growth outlook or margins deteriorate beyond guidance.
- Keep LOW on a housing-turnover watchlist rather than buying the apparent valuation discount now. A more constructive entry requires stabilization in comparable transactions and margins; a further deterioration in housing activity or debt metrics falsifies the recovery setup.
- Treat ADP’s dividend coverage as a watch item, not a standalone buy signal. Check free cash flow after client-fund timing effects alongside pays-per-control and retention; weakening payroll volumes with deteriorating cash conversion would undermine the defensive thesis.
- For JNJ, monitor replacement-product growth against continuing Stelara erosion and legal cash exposure. Avoid extrapolating the payout record into a catalyst; deteriorating operating cash flow or a material adverse legal outcome would outweigh the streak.
More News
- A new analyst call on Home Depot reflects our feeling on what to do with the stock
- This household goods stock has lagged the broader market. Evercore ISI sees a comeback
- RBC Capital raises Johnson & Johnson stock price target on pharma strength
- Evercore ISI upgrades Procter & Gamble stock rating on sales outlook
- Barclays cautious on European airport stocks as airlines curb winter capacity
- Stocks making the biggest moves midday: Marvell, Moderna, Lamb Weston, Constellation Energy & more